DePuy Synthes Spine received 510(k) clearance from the U.S. FDA to market its SYNAPSE Occipital-Cervical-Thoracic System with posterior cervical screws.
This is the first time cervical screws have been indicated for use with a screw-rod posterior fixation system. Previously, screw placement in this system was limited to use for fixation in the thoracic spine (T1-T3) and occiput only.
The system, including SYNAPSE, OC Fusion and AXON, is intended to provide immobilization and stabilization of spinal segments as an adjunct to fusion for a number of acute and chronic instabilities of the craniocervical junction, the cervical spine (C1 to C7) and the thoracic spine (T1-T3).
DePuy Synthes Spine is a part of the DePuy Synthes Companies of Johnson & Johnson.
More articles on devices:
10 key points on J&J's financial report — Medical device sales drop 3.4%
Stryker opens European headquarters — 5 quick facts
Zimmer 4Q sales drop 1.4% — 10 things to know